TY  - JOUR 
AU  - Fernández Díaz, Cristina M. .
AU  - Merino, Beatriz
AU  - López Acosta, J.F.
AU  - Cidad, Pilar
AU  - Fuente, Miguel A. de la
AU  - Lobatón, Carmen D.
AU  - Moreno, Alfredo
AU  - Leissring, Malcolm A.
AU  - Perdomo Hernández, Germán M.
AU  - Cózar Castellano, Irene
PY  - 2019
SN  - 0193-1849
UR  - http://hdl.handle.net/10259/5244
AB  - Inhibition of insulin-degrading enzyme (IDE) has been proposed as a possible therapeutic target for type 2 diabetes treatment. However, many aspects of IDE's role in glucose homeostasis need to be clarified. In light of this, new preclinical models...
LA  - eng
PB  - American Physiological Society
KW  - Endocrinología
KW  - Endocrinology
TI  - Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
DO  - 10.1152/ajpendo.00040.2019
T2  - American Journal of Physiology-Endocrinology and Metabolism
VL  - 317
M2  - E805
ER  -